REVVITY, INC. Form 8-K Summary
Business Context and Reporting Period
Revvity, Inc. (RVTY) filed this Current Report on Form 8-K on January 12, 2025. The filing addresses preliminary expectations for the fourth quarter ended December 29, 2024, and the full year 2024. The Company is scheduled to release its official fourth quarter and full-year 2024 financial results on January 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of upcoming disclosures rather than a detailed financial statement. The Company has securities registered on the New York Stock Exchange, including Common Stock (RVTY) and 1.875% Notes due 2026 (RVTY 26).
Material Changes and Outlook
Management announced preliminary expectations regarding financial performance for the fourth quarter and full year 2024, though specific figures are not included in this filing. The Company will provide a detailed update during an earnings call on January 31, 2025. Additionally, Dr. Prahlad Singh, President and CEO, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
Risks and Contingencies
The filing explicitly states that the information contained herein, including the press release and presentation materials, is furnished and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific revenue and earnings figures in the official press release and earnings call on January 31, 2025.
- Review the presentation materials from the J.P. Morgan Healthcare Conference on January 13, 2025, for strategic updates.
- Confirm the status of the 1.875% Notes due 2026 in subsequent filings.
- Note that the preliminary expectations in this 8-K are not audited financial statements.